Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Roche Discusses Illumina Takeover With Funds, F&W Reports

Don't Miss Out —
Follow us on:

March 31 (Bloomberg) -- Roche Holding AG, which on March 29 raised its hostile bid for Illumina Inc., is in talks with hedge funds that bought Illumina stock following news of the takeover attempt, Finanz & Wirtschaft reported, without saying where it got the information.

Roche, a Basel, Switzerland-based drugmaker, increased its offer to $51 a share after Illumina shareholders told Roche they were interested in accelerating the takeover process, the Swiss newspaper quoted Roche Chief Executive Officer Severin Schwan as saying.

To contact the reporter on this story: Leigh Baldwin in Zurich at

To contact the editor responsible for this story: Mariajose Vera at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.